![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Discovery of MK-4882, a Novel Inhibitor of HCV NS5a with an Attractive Pre-clinical Profile
|
|
|
Reported by Jules Levin AASLD Nov 6-9 2011 San Francisco, CA
Steven W. Ludmerer, Christine Fandozzi, Qian Huang, Stacia Kargman, Rong Liu, Peter Meinke, David B. Olsen, and Craig A. Coburn
Merck Research Laboratories, Whitehouse Station, NJ
![AASLD1.gif](../images/110711/110711-2/AASLD1.gif)
![AASLD2.gif](../images/110711/110711-2/AASLD2.gif)
![AASLD3.gif](../images/110711/110711-2/AASLD3.gif)
![AASLD4.gif](../images/110711/110711-2/AASLD4.gif)
![AASLD5.gif](../images/110711/110711-2/AASLD5.gif)
![AASLD6.gif](../images/110711/110711-2/AASLD6.gif)
![AASLD7.gif](../images/110711/110711-2/AASLD7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|